» Authors » Shera Lilyanna

Shera Lilyanna

Explore the profile of Shera Lilyanna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 122
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ling S, Lilyanna S, Ng J, Chong J, Lin Q, Yong X, et al.
Cell Mol Life Sci . 2024 Jan; 81(1):42. PMID: 38217709
Neprilysin (NEP) is an emerging biomarker for various diseases including heart failure (HF). However, major inter-assay inconsistency in the reported concentrations of circulating NEP and uncertainty with respect to its...
2.
Liew O, Ling S, Lilyanna S, Chong J, Ng J, Richards A
Methods Mol Biol . 2022 Sep; 2578:121-141. PMID: 36152284
This chapter describes an epitope-directed approach to generate antipeptide monoclonal antibodies to multiple nonoverlapping protein sites using a cocktail of fusion peptides as immunogen. It provides a step-by-step protocol on...
3.
Liew O, Fanusi F, Ng J, Ahidjo B, Ling S, Lilyanna S, et al.
ACS Omega . 2022 Jul; 7(29):25510-25520. PMID: 35903176
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) inactivation is an important step toward enhanced biosafety in testing facilities and affords a reduction in the biocontainment level necessary for handling virus-positive biological...
4.
Liew O, Prickett T, Revuelta-Lopez E, Ling S, Cserkoova A, Lupon J, et al.
Clin Biochem . 2022 Mar; 104:51-58. PMID: 35331754
Background: Lack of validation and standardization of research-use-only (RUO) immunoassays brings with it inherent threats to authenticity and functional quality. Poor correlation between different commercial neprilysin RUO immunoassays is concerning...
5.
Liew O, Ling S, Lilyanna S, Zhou Y, Wang P, Chong J, et al.
Commun Biol . 2021 May; 4(1):531. PMID: 33947931
No abstract available.
6.
Liew O, Ling S, Lilyanna S, Zhou Y, Wang P, Chong J, et al.
Commun Biol . 2021 Apr; 4(1):441. PMID: 33824395
High quality, well-validated antibodies are needed to mitigate irreproducibility and clarify conflicting data in science. We describe an epitope-directed monoclonal antibody (mAb) production method that addresses issues of antibody quality,...
7.
Lilyanna S, Ng E, Moriguchi S, Chan S, Kokawa R, Huynh S, et al.
J Appl Lab Med . 2021 Feb; 2(5):687-699. PMID: 33636870
Background: Microplate-based immunoassays are widely used in clinical and research settings to measure a broad range of biomarkers present in complex matrices. Assay variability within and between microplates can give...
8.
Martinez E, Lilyanna S, Wang P, Vardy L, Jiang X, Armugam A, et al.
J Mol Cell Cardiol . 2017 Sep; 112:27-39. PMID: 28865712
Rationale: Myocardial infarction (MI) triggers a dynamic microRNA response with the potential of yielding therapeutic targets. Objective: We aimed to identify novel aberrantly expressed cardiac microRNAs post-MI with potential roles...
9.
Lilyanna S, Peh M, Liew O, Wang P, Moore P, Richards A, et al.
J Mol Cell Cardiol . 2015 Aug; 87:27-37. PMID: 26254181
Aims: Myocardial infarction followed by adverse left ventricular (LV) remodeling is the most frequent proximate cause of heart failure. Hydrogen sulfide (H2S) is an important endogenous modulator of diverse physiological...
10.
Wong L, Wee A, Lim J, Ng J, Chong J, Liew O, et al.
J Mol Cell Cardiol . 2015 Mar; 82:13-21. PMID: 25736855
Natriuretic peptide receptor 3 (NPR3) is the clearance receptor for the cardiac natriuretic peptides (NPs). By modulating the level of NPs, NPR3 plays an important role in cardiovascular homeostasis. Although...